M.V.I.-12 ADULT Drug Patent Profile
✉ Email this page to a colleague
When do M.v.i.-12 Adult patents expire, and when can generic versions of M.v.i.-12 Adult launch?
M.v.i.-12 Adult is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in M.V.I.-12 ADULT is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for M.V.I.-12 ADULT?
- What are the global sales for M.V.I.-12 ADULT?
- What is Average Wholesale Price for M.V.I.-12 ADULT?
Summary for M.V.I.-12 ADULT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | M.V.I.-12 ADULT at DailyMed |
